Phoniex Angellia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Phoniex Angellia has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Christianto Christianto
Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
2 shared publications - Sisca Natalia Siagian
Division of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita, Universitas Indonesia, Jakarta, Indonesia
2 shared publications B M Mendel
National Cardiovascular Center Harapan Kita , Jakarta , Indonesia
1 shared publication- Brian Mendel
Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita, Universitas Indonesia
1 shared publication - Eric Ferdinand
Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
1 shared publication - Grady Krisandi
Division of Forensic Psychiatry, Department of Psychiatry, Faculty of Medicine, University of Indonesia
1 shared publication
Latest Publications
- 1 May 2023
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 19 (3) , 1
The Risk Factors of Acute Coronary Syndrome in Young Women: A Systematic Review and Meta-Analysis
Background: Acute coronary syndrome (ACS) has been one of the leading causes of mortality in the world. Despite common understanding regarding ACS as an older population’s or man's disease, the number of young women affected by this condition is increasing. Many studies have assessed the risk factors of ACS, but only a few studies focused on this subpopulation. Therefore, this systematic review and meta-analysis aim to evaluate the risk factors predisposing to ACS in the young women population. Methods: Nine online databases were screened from the date of inception to September 2021, where the acquired studies were evaluated using the PRISMA statement. The inclusion criteria were a case control study with women age cut-off of <50 years. The risk factors of acute coronary syndrome were analyzed using a random-effect model, expressed as summary statistics of odds ratio (OR) for categorical variable and standard mean difference (SMD) for continuous data with normal distribution, with 95% confidence interval (CI). Quality assessment was conducted using the STROBE statement. Results: Seven studies with the total of 7042 patients met the inclusion criteria of this metaanalysis. Diabetes mellitus, high BMI, obesity, hypercholestrolemia, hypertension, smoking, and family history significantly increased acute coronary syndrome risk in young women. Other risks such as heavy alcohol consumption, oral contraceptive use, and postmenopausal state were associated with higher risk of ACS. Conclusion: The independent risk factors which are strongly related to ACS in young women were diabetes mellitus, hypertension, and hypercholesterolemia with odd ratios of 6.21, 5.32, and 4.07. Other risk factors which may be associated with an increased risk of ACS in young women were heavy alcohol consumption, oral contraceptive use, and postmenopausal state. Health promotion and effective intervention on this specific population regarding these risk factors can decrease young female cardiovascular morbidity and mortality as well as improved quality of life of women.
- 1 May 2023
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 19 (3) , 1
The Risk Factors of Acute Coronary Syndrome in Young Women: A Systematic Review and Meta-Analysis
Background: Acute coronary syndrome (ACS) has been one of the leading causes of mortality in the world. Despite common understanding regarding ACS as an older population’s or man's disease, the number of young women affected by this condition is increasing. Many studies have assessed the risk factors of ACS, but only a few studies focused on this subpopulation. Therefore, this systematic review and meta-analysis aim to evaluate the risk factors predisposing to ACS in the young women population. Methods: Nine online databases were screened from the date of inception to September 2021, where the acquired studies were evaluated using the PRISMA statement. The inclusion criteria were a case control study with women age cut-off of <50 years. The risk factors of acute coronary syndrome were analyzed using a random-effect model, expressed as summary statistics of odds ratio (OR) for categorical variable and standard mean difference (SMD) for continuous data with normal distribution, with 95% confidence interval (CI). Quality assessment was conducted using the STROBE statement. Results: Seven studies with the total of 7042 patients met the inclusion criteria of this metaanalysis. Diabetes mellitus, high BMI, obesity, hypercholestrolemia, hypertension, smoking, and family history significantly increased acute coronary syndrome risk in young women. Other risks such as heavy alcohol consumption, oral contraceptive use, and postmenopausal state were associated with higher risk of ACS. Conclusion: The independent risk factors which are strongly related to ACS in young women were diabetes mellitus, hypertension, and hypercholesterolemia with odd ratios of 6.21, 5.32, and 4.07. Other risk factors which may be associated with an increased risk of ACS in young women were heavy alcohol consumption, oral contraceptive use, and postmenopausal state. Health promotion and effective intervention on this specific population regarding these risk factors can decrease young female cardiovascular morbidity and mortality as well as improved quality of life of women.
- Open Access
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 18 (6) , 1-7
Reversed Potts Shunt Outcome in Suprasystemic Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Background: Reversed Potts shunt has been a prospective approach to treat suprasystemic pulmonary hypertension, particularly when medication treatment fails to reduce right ventricular afterload. Objective: This meta-analysis aims to review the clinical, laboratory, and hemodynamic parameters after a reversed Potts shunt in suprasystemic pulmonary hypertension patients. Methods: Six electronic databases were searched from the date of inception to August 2021, where the obtained studies were evaluated according to the PRISMA statement. The effects of shunt creation were evaluated by comparing preprocedural to postprocedural or follow-up parameters, expressed as a mean difference of 99% confidence interval. Quality assessment was conducted using the STROBE statement. Results: Seven studies suited the inclusion criteria which were included in this article. A reduction in upper and lower limb oxygen saturation [Upper limb: St. Mean difference -0.55, 99% CI -1.25 to 0.15; P=0.04; I2=6%. Lower limb: St. Mean difference –4.45, 99% CI –7.37 to –1.52; P<0.00001; I2=65%]. Reversed Potts shunt was shown to improve WHO functional class, 6-minute walk distance, NTpro-BNP level, and hemodynamic parameters including tricuspid annular plane systolic excursion, interventricular septal curvature, and end-diastolic right ventricle/left ventricle ratio. Conclusion: Reversed Potts shunt cannot be said to be relatively safe, although it allows improvement in the clinical and functional status in patients with suprasystemic PAH. Reversed Potts shunt procedure may be the last resort for drug-resistant pulmonary hypertension as it is considered a high-risk procedure performed on patients with extremely poor conditions.
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 18 (6) , 1-7
Open AccessReversed Potts Shunt Outcome in Suprasystemic Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Background: Reversed Potts shunt has been a prospective approach to treat suprasystemic pulmonary hypertension, particularly when medication treatment fails to reduce right ventricular afterload. Objective: This meta-analysis aims to review the clinical, laboratory, and hemodynamic parameters after a reversed Potts shunt in suprasystemic pulmonary hypertension patients. Methods: Six electronic databases were searched from the date of inception to August 2021, where the obtained studies were evaluated according to the PRISMA statement. The effects of shunt creation were evaluated by comparing preprocedural to postprocedural or follow-up parameters, expressed as a mean difference of 99% confidence interval. Quality assessment was conducted using the STROBE statement. Results: Seven studies suited the inclusion criteria which were included in this article. A reduction in upper and lower limb oxygen saturation [Upper limb: St. Mean difference -0.55, 99% CI -1.25 to 0.15; P=0.04; I2=6%. Lower limb: St. Mean difference –4.45, 99% CI –7.37 to –1.52; P<0.00001; I2=65%]. Reversed Potts shunt was shown to improve WHO functional class, 6-minute walk distance, NTpro-BNP level, and hemodynamic parameters including tricuspid annular plane systolic excursion, interventricular septal curvature, and end-diastolic right ventricle/left ventricle ratio. Conclusion: Reversed Potts shunt cannot be said to be relatively safe, although it allows improvement in the clinical and functional status in patients with suprasystemic PAH. Reversed Potts shunt procedure may be the last resort for drug-resistant pulmonary hypertension as it is considered a high-risk procedure performed on patients with extremely poor conditions.
- Open Access
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Outcomes of heart transplantation in adults and pediatrics congenital heart disease: a systematic review and meta-analysis
Background: Heart transplantation (HTx) has progressed from an experimental therapy option to a well-established therapeutic option for congenital heart disease (CHD) patients in end-stage heart failure, thus we can expect a large number of people with CHD to be evaluated for HTx in the next decades. Objective: To create a systematic review and meta-analysis regarding short-term and long-term outcomes of HTx in end-stage adults and pediatrics CHD patients. Methods: Four online databases were screened from the date of inception to January 2022, where the acquired studies were assessed using the PRISMA statement. The inclusion criteria were cohort studies that evaluated outcomes of heart transplantation in end-stage congenital heart disease patients. The mortality of adults and pediatrics population were analyzed using random-effect model, showed as summary statistics of overall risk ratio (RR) with 95% confidence interval (CI). Quality appraisal was conducted using the STROBE statement. Result: Ten studies met the inclusion criteria and were eligible to be analyzed. The pediatric population had stronger 1-year mortality risk [Std. Mean difference 0.62, 95% CI, 0.12 to 3.07; P<0.00001] and 5-year mortality risk [Std. Mean difference 0.82, 95% CI, 0.37 to 1.84; P<0.00001], while adult population were found to have higher overall post-transplantation mortality risk [Std. mean difference 1.17, 95% CI 0.66 to 2.08; P<0.00001]. Conclusion: Adults CHD patients experienced higher mortality rate following heart transplantation, with improved long-term survival in comparison to pediatrics CHD recipients. However, further study should be conducted with standardized subjects as there is moderate quality of evidence and higher heterogeneity during our meta-analysis. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Open AccessOutcomes of heart transplantation in adults and pediatrics congenital heart disease: a systematic review and meta-analysis
Background: Heart transplantation (HTx) has progressed from an experimental therapy option to a well-established therapeutic option for congenital heart disease (CHD) patients in end-stage heart failure, thus we can expect a large number of people with CHD to be evaluated for HTx in the next decades. Objective: To create a systematic review and meta-analysis regarding short-term and long-term outcomes of HTx in end-stage adults and pediatrics CHD patients. Methods: Four online databases were screened from the date of inception to January 2022, where the acquired studies were assessed using the PRISMA statement. The inclusion criteria were cohort studies that evaluated outcomes of heart transplantation in end-stage congenital heart disease patients. The mortality of adults and pediatrics population were analyzed using random-effect model, showed as summary statistics of overall risk ratio (RR) with 95% confidence interval (CI). Quality appraisal was conducted using the STROBE statement. Result: Ten studies met the inclusion criteria and were eligible to be analyzed. The pediatric population had stronger 1-year mortality risk [Std. Mean difference 0.62, 95% CI, 0.12 to 3.07; P<0.00001] and 5-year mortality risk [Std. Mean difference 0.82, 95% CI, 0.37 to 1.84; P<0.00001], while adult population were found to have higher overall post-transplantation mortality risk [Std. mean difference 1.17, 95% CI 0.66 to 2.08; P<0.00001]. Conclusion: Adults CHD patients experienced higher mortality rate following heart transplantation, with improved long-term survival in comparison to pediatrics CHD recipients. However, further study should be conducted with standardized subjects as there is moderate quality of evidence and higher heterogeneity during our meta-analysis. Funding Acknowledgement: Type of funding sources: None.